The global sepsis diagnostics market is estimated to reach USD 613.9 million by 2023 from USD 396.6 billion in 2018, at a CAGR of 9.1% from 2018 to 2023. Rising prevalence of sepsis across the globe, increasing geriatric population, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis diagnosis during the study period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=92673155
In this report, the market has been segmented by technology, product, pathogen, method, test type, end user, and region.
On the basis of technology, the global sepsis diagnostic market is segmented into microbiology, molecular diagnostics, immunoassay, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. Biomarkers offer various advantages in the diagnosis of sepsis as they help identify and differentiate bacterial infection from fungal infection and provide early intervention of disease diagnosis.
On the basis of products, the global sepsis diagnostics market is segmented into blood culture media, assays & reagents, instruments, and software. The blood culture media segment is expected to grow at the highest CAGR during the forecast period owing to the increased used of blood culture media as it is the standard method for diagnosis of sepsis across the globe.
On the basis of pathogens, the global sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and other pathogens. The bacterial sepsis segment is expected to grow at the highest CAGR during the forecast period growing number of bacterial sepsis cases and increasing number of surgical procedures across the globe.
On the basis of method, the sepsis diagnostics market is categorized into two segments—conventional diagnostics and automated diagnostics. The automated diagnostics segment is expected to be the fastest-growing segment of the global sepsis diagnostics market during the forecast period. Accurate detection of positive blood cultures, quick turnaround time, and reduced risk of contamination are the key factors contributing to the growth of this segment in the global sepsis diagnostics market.
On the basis of test type, the sepsis diagnostics market is further segmented into laboratory tests and point-of-care tests. The point-of-care tests segment is expected to grow at the highest CAGR during the forecast period owing to the increasing technological advancements and rising adoption of POC testing devices across the globe.
On the basis of end users, the sepsis diagnostics market is segmented into hospitals and pathology & reference laboratories. The hospitals segment is expected to be the fastest-growing segment of the sepsis diagnostics market during the forecast period. The growth of this segment can be attributed to the high prevalence of sepsis among ICU patients across the globe and the increasing number of initiatives taken by hospitals to identify and diagnose sepsis.
Based on region, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The sepsis diagnostics market in Asia Pacific is projected to register the highest CAGR during the forecast period. The high prevalence of sepsis, increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, rising focus of global players, and rapid growth in the aging population are driving the growth of the sepsis diagnostics market in the Asia Pacific region.
In addition, emerging markets such as China, India, and Brazil are expected to offer significant growth opportunities for market players owing to the rising focus of local governments to improve healthcare infrastructure of countries and the presence of large patient pool.
